A, M., M, S., U, B., M, S., & K, G. (2020). Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press.
Style de citation Chicago (17e éd.)A, Mehta, Saifi M, Batra U, Suryavanshi M, et Gupta K. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press, 2020.
Style de citation MLA (8e éd.)A, Mehta, et al. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients. Dove Medical Press, 2020.
Attention : ces citations peuvent ne pas être correctes à 100%.